MD20150089A2 - Formă preparativă farmaceutică conţinând fosfatidilcolină pentru tratarea colitei ulceroase - Google Patents

Formă preparativă farmaceutică conţinând fosfatidilcolină pentru tratarea colitei ulceroase

Info

Publication number
MD20150089A2
MD20150089A2 MDA20150089A MD20150089A MD20150089A2 MD 20150089 A2 MD20150089 A2 MD 20150089A2 MD A20150089 A MDA20150089 A MD A20150089A MD 20150089 A MD20150089 A MD 20150089A MD 20150089 A2 MD20150089 A2 MD 20150089A2
Authority
MD
Moldova
Prior art keywords
acid
pharmaceutical formulation
phosphatidylcholine
ulcerative colitis
treatment
Prior art date
Application number
MDA20150089A
Other languages
English (en)
Russian (ru)
Inventor
Герхард КАЙЛХАУЭР
Original Assignee
Lipid Therapeutics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lipid Therapeutics Gmbh filed Critical Lipid Therapeutics Gmbh
Publication of MD20150089A2 publication Critical patent/MD20150089A2/ro

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/284Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5026Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Invenţia se referă la o formă preparativă farmaceutică care conţine un produs de fosfatidilcolină cu formula (I),unde R1 reprezintă radicalul unui acid gras saturat sau nesaturat cu 12...24 atomi de carbon, iar R2 reprezintă radicalul unui acid gras saturat sau nesaturat cu 12...24 atomi de carbon, şi unde produsul de fosfatidilcolină (FC) conţine următoarele cantităţi de acizi graşi (% mas. din cantitatea totală de acizi graşi din FC): 55…72 acid linoleic; 10…18 acid palmitic; 7…15 acid oleic; 2…8 acid linolenic; 2…8 acid stearic, şi cel puţin un excipient acceptabil farmaceutic pentru eliberarea întârziată; precum şi la un procedeu de preparare a formei preparative menţionate.Forma propusă poate fi utilizată pentru tratamentul îmbunătăţit sau prevenirea colitei ulceroase.
MDA20150089A 2013-03-26 2014-03-25 Formă preparativă farmaceutică conţinând fosfatidilcolină pentru tratarea colitei ulceroase MD20150089A2 (ro)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13161089 2013-03-26
PCT/EP2014/055947 WO2014154683A1 (en) 2013-03-26 2014-03-25 Pharmaceutical formulation comprising phosphatidylcholine for the treatment of ulcerative colitis

Publications (1)

Publication Number Publication Date
MD20150089A2 true MD20150089A2 (ro) 2016-03-31

Family

ID=47913311

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20150089A MD20150089A2 (ro) 2013-03-26 2014-03-25 Formă preparativă farmaceutică conţinând fosfatidilcolină pentru tratarea colitei ulceroase

Country Status (26)

Country Link
US (1) US20160045523A1 (ro)
EP (1) EP2978416B1 (ro)
JP (1) JP6262843B2 (ro)
KR (1) KR20150132841A (ro)
CN (1) CN105377247B (ro)
AU (1) AU2014243102B2 (ro)
BR (1) BR112015023849A2 (ro)
CA (1) CA2907401A1 (ro)
CL (1) CL2015002832A1 (ro)
DK (1) DK2978416T3 (ro)
EA (1) EA029514B1 (ro)
ES (1) ES2605650T3 (ro)
HK (1) HK1217089A1 (ro)
HU (1) HUE030707T2 (ro)
IL (1) IL241019A0 (ro)
LT (1) LT2978416T (ro)
MD (1) MD20150089A2 (ro)
MX (1) MX2015013511A (ro)
PE (1) PE20160037A1 (ro)
PH (1) PH12015502199A1 (ro)
PL (1) PL2978416T3 (ro)
PT (1) PT2978416T (ro)
SG (1) SG11201507777TA (ro)
UA (1) UA115585C2 (ro)
WO (1) WO2014154683A1 (ro)
ZA (1) ZA201507910B (ro)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ595080A (en) 2009-02-16 2013-09-27 Giuliani Int Ltd Methods of treating hair related conditions
JP6301844B2 (ja) 2012-02-09 2018-03-28 ノグラ ファーマ リミテッド 線維症の処置方法
WO2017144725A1 (en) * 2016-02-26 2017-08-31 Nogra Pharma Limited Methods of treating lactose intolerance
CA3128302A1 (en) 2019-02-08 2020-08-13 Nogra Pharma Limited Process of making 3-(4'-aminophenyl)-2-methoxypropionic acid, and analogs and intermediates thereof
EP3936123A4 (en) * 2019-03-05 2023-05-17 Sichuan Gowell Pharmaceutical Co., Ltd. FATTY ACID COMPOSITION AND USE THEREOF
CN113368118B (zh) * 2021-07-21 2022-09-23 中国药科大学 磷脂酰胆碱在制备治疗溃疡性结肠炎的药物中的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3022136C2 (de) * 1980-06-13 1986-07-17 A. Nattermann & Cie GmbH, 5000 Köln Verfahren zum Abfüllen von Phospholipide enthaltenden pharmazeutischen Massen in Hartkapseln
US4560655A (en) * 1982-12-16 1985-12-24 Immunex Corporation Serum-free cell culture medium and process for making same
IT1243981B (it) * 1990-10-01 1994-06-28 Fidia Spa Composizioni per il trattamento della pelle contenenti derivati della b-fosfatidilcolina
US5453523A (en) * 1993-06-16 1995-09-26 Emulsion Technology, Inc. Process for obtaining highly purified phosphatidylcholine
US5840332A (en) * 1996-01-18 1998-11-24 Perio Products Ltd. Gastrointestinal drug delivery system
ES2211184T3 (es) * 1998-08-06 2004-07-01 Wolfgang Stremmel Fosfatidilcolina como medicamento con efecto protector de mucosas.
ES2452351T3 (es) * 2007-07-31 2014-04-01 Pat Gmbh Uso de fosfatidilcolina para el tratamiento de colitis ulcerosa dependiente de esteroides y refractaria a esteroides
CN102633832B (zh) * 2011-02-09 2015-07-22 北京绿色金可生物技术股份有限公司 一种制备高纯度磷脂酰胆碱的方法

Also Published As

Publication number Publication date
DK2978416T3 (en) 2016-12-19
CN105377247A (zh) 2016-03-02
US20160045523A1 (en) 2016-02-18
PT2978416T (pt) 2016-12-09
EP2978416A1 (en) 2016-02-03
SG11201507777TA (en) 2015-10-29
JP2016516087A (ja) 2016-06-02
BR112015023849A2 (pt) 2017-07-18
KR20150132841A (ko) 2015-11-26
ES2605650T3 (es) 2017-03-15
UA115585C2 (uk) 2017-11-27
HUE030707T2 (en) 2017-05-29
CN105377247B (zh) 2019-04-26
IL241019A0 (en) 2015-11-30
ZA201507910B (en) 2017-04-26
HK1217089A1 (zh) 2016-12-23
AU2014243102A1 (en) 2015-09-17
AU2014243102B2 (en) 2018-04-26
MX2015013511A (es) 2016-06-28
JP6262843B2 (ja) 2018-01-17
EP2978416B1 (en) 2016-10-26
CL2015002832A1 (es) 2016-03-11
WO2014154683A1 (en) 2014-10-02
LT2978416T (lt) 2016-12-12
CA2907401A1 (en) 2014-10-02
PH12015502199A1 (en) 2016-01-25
PL2978416T3 (pl) 2017-03-31
EA201591510A1 (ru) 2016-01-29
EA029514B1 (ru) 2018-04-30
PE20160037A1 (es) 2016-02-04

Similar Documents

Publication Publication Date Title
MD20150089A2 (ro) Formă preparativă farmaceutică conţinând fosfatidilcolină pentru tratarea colitei ulceroase
CL2019003105A1 (es) Lípidos extraídos de plantas que comprenden ácidos grasos poliinsaturados de cadena larga. (divisional solicitud 201601560)
WO2014167554A3 (en) Composition and formulation of antimicrobial agents, processes thereof and methods for treating microbial infections
MY198214A (en) Fatty acid composition and use thereof
MY188027A (en) Fat composition and fat blend
NZ709486A (en) Solid solution compositions and use in chronic inflammation
MX355572B (es) Metodo para la preparacion de trigliceridos de acidos grasos de cadena media.
MX342216B (es) Composiciones de acidos grasos.
WO2011097276A8 (en) Methods and compositions for treating arthritis with docosahexaenoic acid
WO2015011724A3 (en) A novel omega -3 fatty acid composition with a plant extract
NZ747847A (en) Lipid compositions
MA40417A (fr) Mélange d'acides gras et de palmitoyl éthanolamide pour utilisation dans le traitement de pathologies inflammatoires et allergiques
WO2014165190A3 (en) Compositions comprising docosapentaenoic acid and methods of use
WO2013190455A3 (en) Process for the preparation of lurasidone hydrochloride
MX2021001790A (es) Composiciones solidas de trigliceridos y usos de estas.
PH12017500738A1 (en) Feeding algae to cattle at low doses to produce high omega 3 levels in beef
MY181680A (en) Use of sulfonic acid for recovering glycerol resulting from the triglyceride transesterification reaction
WO2014096165A3 (en) Gas-filled microvesicles
IN2015DN00102A (ro)
CN106687441A8 (zh) 用于将第一化合物偶合到第二化合物的方法
CO2018012463A2 (es) Composición de lípidos en polvo que comprende una mezcla de sal
PH12015500793B1 (en) Control agent for plant pest and/or plant disease
CO7240409A2 (es) Compuestos a partir de los frutos de acrocomia crispa y acromia aculeata contra la inflamación y el estres oxidativo
PH12019501046A1 (en) Acid composition for the treatment of fatty acids
MY182731A (en) Fat composition

Legal Events

Date Code Title Description
FA9A Abandonment or withdrawal of application (patent for invention)